Mesenchymal stromal cells to treat patients with non‐ischaemic heart failure: Results from SCIENCE II pilot study

Mesenchymal stromal cells to treat patients with non‐ischaemic heart failure: Results from SCIENCE II pilot study

Abstract Aims Allogeneic stem cell therapy is more logistically suitable compared with autologous cell therapy for large‐scale patient treatment. We aim to investigate the clinical safety and efficacy profile of the allogeneic adipose tissue derived mesenchymal stromal cell product (CSCC_ASC) as an...

Full description

Saved in:
Bibliographic Details
Main Authors: Abbas Ali Qayyum, Sabina Frljak, Morten Juhl, Gregor Poglajen, Gregor Zemljičl, Andraz Cerar, Thomas Litman, Annette Ekblond, Mandana Haack‐Sørensen, Lisbeth Drozd Højgaard, Jens Kastrup, Bojan Vrtovec
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:ESC Heart Failure
Subjects:
Adipose tissue derived mesenchymal stromal cells
Allogeneic therapy
Clinical trial
Heart failure
Stem cells
Online Access:https://doi.org/10.1002/ehf2.14925
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/ehf2.14925

Similar Items